Purdue Pharma LP pleaded guilty to criminal charges over the handling of the company’s addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker’s role in the U.S. opioid crisis.
Walmart Inc. filed a lawsuit against the federal government, seeking clarity on the roles and legal responsibilities of pharmacists and pharmacies in filling opioid prescriptions.
O.C Suboxone understands the severity of opioid use disorder and is working to raise awareness on healthier alternatives to treat chronic pain.
Addressing Spikes in Substance Use Disorder Following COVID-19 Date: Wednesday, September 23, 2020 Time: 01:00 – 02:00 PM EDT Duration: 1 Hour Register Here As communities worry about a second spike in COVID-19, many are overlooking the current spike in substance use disorder (SUD). Prolonged social isolation, heightened anxiety and depression, and a […]
Much more often than not, attempting to talk to friends or family members about their potential drug or alcohol abuse is a sensitive, challenging, and sometimes painful undertaking. It is natural for an individual who is addicted to drugs or alcohol, not to recognize the long-term consequences that cause pain and suffering to more people than just themselves. When seeking to help others overcome their addiction and the constant struggle with substance abuse, sometimes it is through those caring friends or family members that the user can finally find some relief2 by setting boundaries.
Med Ad News spoke with Christian Heidbreder, Ph.D., Chief Scientific Officer of Indivior Inc., about some of the barriers to patients seeking treatment for opioid use disorder, how to integrate treatment for opioid use disorder and infectious disease services, and the company’s efforts to provide treatments for those struggling with the disorder.
The first of the Insys Therapeutics executives found guilty of violating the Racketeer Influenced and Corrupt Organizations (RICO) Act in May 2019 was sentenced to 33 months in federal prison.
Nektar Therapeutics withdrew the application for the company’s opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration panel unanimously voted against the drug’s approval.
Insights into former president Richard Sackler’s control of Purdue Pharma and his aggressive stance on marketing OxyContin were revealed when internal company documents were unsealed following a four-year court battle in Kentucky.
A federal judge partially overturned the convictions of Insys Therapeutics Inc.’s founder and three former executives accused of bribing doctors to prescribe an addictive opioid, but declined to disturb the remainder of the jury’s verdict.